Low COVID-19 Vaccine Coverage Undermines Eastern Mediterranean’s Plans To Welcome Pilgrims and Football Fans 20/04/2022 Aishwarya Tendolkar Some 42% of the World Health Organization’s (WHO) Eastern Mediterranean is fully vaccinated, but only five of the 22 member states have met the global goal of vaccinating 70% of their populations despite enough vaccine stocks being available, according to a media briefing on Wednesday. WHO Region Director for Eastern Mediterranean, Dr Ahmed Al-Mandhari, ascribed […] Continue reading -> ‘Missing’ India Air Pollution Data Restored to WHO Air Quality Database 19/04/2022 Elaine Ruth Fletcher India’s air quality data, removed at the last minute from the WHO Air Quality database update just prior to its launch two weeks ago, has been restored again to the online repository. The omission of data from dozens of cities in one of the world’s most polluted nations went unnoticed by major media until it […] Continue reading -> Following USA – WHO Reports on Wave of Acute Childhood Hepatitis in the UK and Ireland 18/04/2022 Elaine Ruth Fletcher The World Health Organization has reported that it is investigating some 74 cases of acute childhood hepatitis, of an unknown origin, in the United Kingdom along with five suspected and confirmed cases in the Republic of Ireland. That follows on previous reports of similar, severe hepatitis cases of an unknown origin among a cluster of […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> EXCLUSIVE: WHO Deleted India’s Air Pollution Data from its New Air Quality Database – Why? 14/04/2022 Elaine Ruth Fletcher & Jyoti Pande Lavakare Nearly ten years of air pollution data for dozens of Indian cities – among the most polluted in the world – was deleted from the latest World Health Organization Air Quality database just before WHO published the report on 4 April 2022, Health Policy Watch has learned. The Indian air quality data, spanning the years […] Continue reading -> COVID-19 Pandemic Still Poses a Danger Despite Lower Case Rates, Says WHO 13/04/2022 Aishwarya Tendolkar COVID-19 affiliated deaths last week were the lowest on record globally since the pandemic began two years ago. But the World Health Organisation (WHO) today emphasized that the pandemic remains a public health emergency and we must not drop our guards. “This is the moment to work even harder to save lives,” said Dr Tedros […] Continue reading -> Global Health Matters: Around the World of Public Health in Audio 13/04/2022 Maayan Hoffman After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Non-Communicable Diseases: Is the ‘New Normal’ Too Much Like The Old One? 11/04/2022 Katie Dain & David Watkins More than two years after the novel coronavirus erupted into a global pandemic, the world is beginning to settle into a new normal. COVID-19 changed how we live and work in ways that will continue long after the pandemic subsides. Digital and automation technologies are here to stay, work is done remotely, and shopping and […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Missing’ India Air Pollution Data Restored to WHO Air Quality Database 19/04/2022 Elaine Ruth Fletcher India’s air quality data, removed at the last minute from the WHO Air Quality database update just prior to its launch two weeks ago, has been restored again to the online repository. The omission of data from dozens of cities in one of the world’s most polluted nations went unnoticed by major media until it […] Continue reading -> Following USA – WHO Reports on Wave of Acute Childhood Hepatitis in the UK and Ireland 18/04/2022 Elaine Ruth Fletcher The World Health Organization has reported that it is investigating some 74 cases of acute childhood hepatitis, of an unknown origin, in the United Kingdom along with five suspected and confirmed cases in the Republic of Ireland. That follows on previous reports of similar, severe hepatitis cases of an unknown origin among a cluster of […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> EXCLUSIVE: WHO Deleted India’s Air Pollution Data from its New Air Quality Database – Why? 14/04/2022 Elaine Ruth Fletcher & Jyoti Pande Lavakare Nearly ten years of air pollution data for dozens of Indian cities – among the most polluted in the world – was deleted from the latest World Health Organization Air Quality database just before WHO published the report on 4 April 2022, Health Policy Watch has learned. The Indian air quality data, spanning the years […] Continue reading -> COVID-19 Pandemic Still Poses a Danger Despite Lower Case Rates, Says WHO 13/04/2022 Aishwarya Tendolkar COVID-19 affiliated deaths last week were the lowest on record globally since the pandemic began two years ago. But the World Health Organisation (WHO) today emphasized that the pandemic remains a public health emergency and we must not drop our guards. “This is the moment to work even harder to save lives,” said Dr Tedros […] Continue reading -> Global Health Matters: Around the World of Public Health in Audio 13/04/2022 Maayan Hoffman After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Non-Communicable Diseases: Is the ‘New Normal’ Too Much Like The Old One? 11/04/2022 Katie Dain & David Watkins More than two years after the novel coronavirus erupted into a global pandemic, the world is beginning to settle into a new normal. COVID-19 changed how we live and work in ways that will continue long after the pandemic subsides. Digital and automation technologies are here to stay, work is done remotely, and shopping and […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Following USA – WHO Reports on Wave of Acute Childhood Hepatitis in the UK and Ireland 18/04/2022 Elaine Ruth Fletcher The World Health Organization has reported that it is investigating some 74 cases of acute childhood hepatitis, of an unknown origin, in the United Kingdom along with five suspected and confirmed cases in the Republic of Ireland. That follows on previous reports of similar, severe hepatitis cases of an unknown origin among a cluster of […] Continue reading -> Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> EXCLUSIVE: WHO Deleted India’s Air Pollution Data from its New Air Quality Database – Why? 14/04/2022 Elaine Ruth Fletcher & Jyoti Pande Lavakare Nearly ten years of air pollution data for dozens of Indian cities – among the most polluted in the world – was deleted from the latest World Health Organization Air Quality database just before WHO published the report on 4 April 2022, Health Policy Watch has learned. The Indian air quality data, spanning the years […] Continue reading -> COVID-19 Pandemic Still Poses a Danger Despite Lower Case Rates, Says WHO 13/04/2022 Aishwarya Tendolkar COVID-19 affiliated deaths last week were the lowest on record globally since the pandemic began two years ago. But the World Health Organisation (WHO) today emphasized that the pandemic remains a public health emergency and we must not drop our guards. “This is the moment to work even harder to save lives,” said Dr Tedros […] Continue reading -> Global Health Matters: Around the World of Public Health in Audio 13/04/2022 Maayan Hoffman After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Non-Communicable Diseases: Is the ‘New Normal’ Too Much Like The Old One? 11/04/2022 Katie Dain & David Watkins More than two years after the novel coronavirus erupted into a global pandemic, the world is beginning to settle into a new normal. COVID-19 changed how we live and work in ways that will continue long after the pandemic subsides. Digital and automation technologies are here to stay, work is done remotely, and shopping and […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Data-Sharing in the Time of COVID – Could Researchers Agree to Use a Common Clinical Trial ‘Repository’? 15/04/2022 Elaine Ruth Fletcher Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work. The vision is of a common clinical-trial […] Continue reading -> EXCLUSIVE: WHO Deleted India’s Air Pollution Data from its New Air Quality Database – Why? 14/04/2022 Elaine Ruth Fletcher & Jyoti Pande Lavakare Nearly ten years of air pollution data for dozens of Indian cities – among the most polluted in the world – was deleted from the latest World Health Organization Air Quality database just before WHO published the report on 4 April 2022, Health Policy Watch has learned. The Indian air quality data, spanning the years […] Continue reading -> COVID-19 Pandemic Still Poses a Danger Despite Lower Case Rates, Says WHO 13/04/2022 Aishwarya Tendolkar COVID-19 affiliated deaths last week were the lowest on record globally since the pandemic began two years ago. But the World Health Organisation (WHO) today emphasized that the pandemic remains a public health emergency and we must not drop our guards. “This is the moment to work even harder to save lives,” said Dr Tedros […] Continue reading -> Global Health Matters: Around the World of Public Health in Audio 13/04/2022 Maayan Hoffman After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Non-Communicable Diseases: Is the ‘New Normal’ Too Much Like The Old One? 11/04/2022 Katie Dain & David Watkins More than two years after the novel coronavirus erupted into a global pandemic, the world is beginning to settle into a new normal. COVID-19 changed how we live and work in ways that will continue long after the pandemic subsides. Digital and automation technologies are here to stay, work is done remotely, and shopping and […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EXCLUSIVE: WHO Deleted India’s Air Pollution Data from its New Air Quality Database – Why? 14/04/2022 Elaine Ruth Fletcher & Jyoti Pande Lavakare Nearly ten years of air pollution data for dozens of Indian cities – among the most polluted in the world – was deleted from the latest World Health Organization Air Quality database just before WHO published the report on 4 April 2022, Health Policy Watch has learned. The Indian air quality data, spanning the years […] Continue reading -> COVID-19 Pandemic Still Poses a Danger Despite Lower Case Rates, Says WHO 13/04/2022 Aishwarya Tendolkar COVID-19 affiliated deaths last week were the lowest on record globally since the pandemic began two years ago. But the World Health Organisation (WHO) today emphasized that the pandemic remains a public health emergency and we must not drop our guards. “This is the moment to work even harder to save lives,” said Dr Tedros […] Continue reading -> Global Health Matters: Around the World of Public Health in Audio 13/04/2022 Maayan Hoffman After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Non-Communicable Diseases: Is the ‘New Normal’ Too Much Like The Old One? 11/04/2022 Katie Dain & David Watkins More than two years after the novel coronavirus erupted into a global pandemic, the world is beginning to settle into a new normal. COVID-19 changed how we live and work in ways that will continue long after the pandemic subsides. Digital and automation technologies are here to stay, work is done remotely, and shopping and […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Pandemic Still Poses a Danger Despite Lower Case Rates, Says WHO 13/04/2022 Aishwarya Tendolkar COVID-19 affiliated deaths last week were the lowest on record globally since the pandemic began two years ago. But the World Health Organisation (WHO) today emphasized that the pandemic remains a public health emergency and we must not drop our guards. “This is the moment to work even harder to save lives,” said Dr Tedros […] Continue reading -> Global Health Matters: Around the World of Public Health in Audio 13/04/2022 Maayan Hoffman After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Non-Communicable Diseases: Is the ‘New Normal’ Too Much Like The Old One? 11/04/2022 Katie Dain & David Watkins More than two years after the novel coronavirus erupted into a global pandemic, the world is beginning to settle into a new normal. COVID-19 changed how we live and work in ways that will continue long after the pandemic subsides. Digital and automation technologies are here to stay, work is done remotely, and shopping and […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Health Matters: Around the World of Public Health in Audio 13/04/2022 Maayan Hoffman After Dr Garry Aslanyan became an avid follower of podcasts, he realized there was a dearth of material from the genre in his own global health field. So he set out to fill that gap with a new series featuring public health professionals and policymakers from around the world who have made a difference – […] Continue reading -> Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Non-Communicable Diseases: Is the ‘New Normal’ Too Much Like The Old One? 11/04/2022 Katie Dain & David Watkins More than two years after the novel coronavirus erupted into a global pandemic, the world is beginning to settle into a new normal. COVID-19 changed how we live and work in ways that will continue long after the pandemic subsides. Digital and automation technologies are here to stay, work is done remotely, and shopping and […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Championing Health Equity in South Africa – Global Health Matters Podcast Series 13/04/2022 Editorial team The second season of the Global Health Matters podcast series kicks off with a close-up look at South Africa’s health equity initiatives and champions. Health Policy Watch will be featuring episodes from the series throughout the coming year as part of a TDR-supported series. As the world commits to equitable access to medicines and vaccines, […] Continue reading -> Non-Communicable Diseases: Is the ‘New Normal’ Too Much Like The Old One? 11/04/2022 Katie Dain & David Watkins More than two years after the novel coronavirus erupted into a global pandemic, the world is beginning to settle into a new normal. COVID-19 changed how we live and work in ways that will continue long after the pandemic subsides. Digital and automation technologies are here to stay, work is done remotely, and shopping and […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Non-Communicable Diseases: Is the ‘New Normal’ Too Much Like The Old One? 11/04/2022 Katie Dain & David Watkins More than two years after the novel coronavirus erupted into a global pandemic, the world is beginning to settle into a new normal. COVID-19 changed how we live and work in ways that will continue long after the pandemic subsides. Digital and automation technologies are here to stay, work is done remotely, and shopping and […] Continue reading -> Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Artificial Intelligence ‘Boot Camp’ Aims to Accelerate Drug Discovery 08/04/2022 Maayan Hoffman TEL AVIV – Ninety percent of drug candidates fail in clinical trials because of unexpected safety issues or lack of efficacy in human subjects, according to Noga Yerushalmi, Investment Director at M Ventures, the strategic, corporate venture capital arm of Merck. There have been dramatic improvements in omics technologies – that is the collective technologies […] Continue reading -> Posts navigation Older postsNewer posts